Stem cell research and development as well as technologies, tools and treatments continued to develop better rapid pace.  Stem cell research can no longer be considered in its infancy in regard to recent discoveries, though knowledge and information gained from decades of research has promoted the development of new therapies, treatment protocols and if it to see ratings in a number of the world's leading medical conditions.

Common Stem Cell Research and Treatment Focus
Today, stem cell research and development offers an enhanced focused on neurological and neuromuscular conditions.  Some of the most common of these include:

• Parkinson's and Alzheimer's disease
• Epilepsy
• Multiple sclerosis
• Muscular dystrophy
• Autism
• Diabetes
• Brain damage caused by a traumatic brain injury or stroke
• Cerebral palsy
• Chronic pain
• Rheumatoid arthritis

Clinical trials in countries around the world offer patients diagnosed with a number of conditions hope, enhance mobility, a slowing progression of disease processes, and improved quality of life. Stem cell research and development is underway in the United States, though no stem cell therapies or treatments have been approved to date. Stage one and stage two clinical trials are currently underway regarding a number of stem cell treatments, and treatments and therapies are currently being offered in for in locations such as Mexico and South America, Southeast Asia and Europe, with promising results.

Types of Stem Cells under Development
Fetal, umbilical, embryonic and adult stem cell research and technologies has been underway for many years, newer stem cell discoveries involving umbilical cord and placenta stem cells are underway. Not all stem cells are created equal.

Adult stem cells are taken from bone marrow. Adult stem cells can be "instructed" to form a certain type of cell, such as nerve cells, cardiac cells, skin cells, and muscle cells.

Embryonic stem cells are taken from embryonic tissues, most commonly from discarded embryos developed from in-vitro fertilization procedures, with informed consent from donors. Undifferentiated, or unspecified embryonic stem cell cultures may be gently coerced through scientific methods to form into different types of cells, including nerve cells, muscle cells, and cardiac or heart muscle cells.

Multipotent stem cells are readily available from placental tissues typically discarded after the birth of a baby. No harm is done to mother or baby. Placental tissues have been shown to treat such diseases as, among many others: Parkinson’s and Alzheimer’s disease, autoimmune disorders, stroke, lupus, muscular dystrophy and cerebral palsy.

Umbilical stem cell collection and their potential use for future therapies are growing in popularity around the world. Blood found within the umbilical cord could supply blood-forming stem cells, and they began to collect and store them in stem cell banks.  These stem cells are capable of turning into three types of mature blood cells that are found in all humans, such as red and white blood cells, and platelets.

Stem cell research may potentially treat and cure debilitating and life-threatening illnesses and disease processes such as diabetes, Parkinson's, Alzheimer's, cancer, and repair of cardiac muscle tissues damaged by strokes, heart attacks, and coronary artery disease. Developments in stem cell research have proven positive results from using stem cells in a variety of treatments of blood disorders such as leukemia as well as vision care and cardiac care.

Overcoming Obstacles
One of the greatest obstacles for patients receiving transplants or stem cell therapies is the chance of rejection by the immune system. Researchers and medical developers are seeking ways to overcoming such obstacles when it comes to stem cell treatments and therapies.  To date, stem cell researchers and scientists have learned how to reprogram adult stem cells into pluripotent stem cells, which give them a greater opportunity of developing into desired types of tissues such as skin, muscle, organs, blood vessel and nerve.

In order to enhance the efficacy of such therapies, researchers at Stanford University in California are working on blocking agents or immune system drugs that decrease the chance of rejection of foreign stem cells or tissues, enhancing the efficacy of treatments and benefits from donors.

PlacidWay, an international medical travel services provider and resource offers individuals around the world information regarding stem cell research and development as well as physicals and facilities specializing in various types of globally available stem cell treatments and therapies.

Please Click here to request more information and Click here for Medical Centers.